Live Company Group (LON:LVCG), His Excellency Mr. Bernard Fautrier, Vice-President and Chief Executive Officer of the Foundation and David Ciclitira, Chairman of the Company, today announced that the Foundation, LVCG,..
CentralNic Group Plc (LON:CNIC) CEO Ben Crawford joins DirectorsTalk to discuss its latest acquisition ‘Globehosting’. Ben explains who Globehosting are, how the company fits with CNIC, how it fits with..
1PM PLC (LON:OPM) is the topic of conversation when Hardman & Co Analyst Mark Thomas joins Directorstalk. Mark talks about the recent article “give credit where it is due” and..
Greene King Plc (LON:GNK) will make the following trading statement for the 18 weeks to 2nd September 2018. The positive momentum in Pub Company continued through the summer with like-for-like..
Altus Strategies Plc (LON:ALS & TSX-V: ALTS) CEO Steve Poulton talks to DirectorsTalk about a Letter of Intent with Raptor in Morocco. Steve provides us with some info about the..
AstraZeneca Plc (LON:AZN) and its partner Amgen Inc. (Amgen) announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for tezepelumab in patients with severe asthma,..
Gresham House Plc, (LON:GHE) the specialist alternative asset manager, has announced today that, with immediate effect, Canaccord Genuity Limited has been appointed as the Group’s Nominated Adviser and Joint Broker;..
ImmuPharma PLC (LON:IMM), the specialist drug discovery and development company today announced a corporate update. Key highlights: · Lupuzor™ o Agreement signed to enter Lupuzor™ into a ‘Managed Access Programme’..
